News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Myogen (MYOG) Release: Darusentan Data To Be Presented At ISH 2006 • Fukuoka, Japan


10/18/2006 11:49:44 AM

DENVER--(BUSINESS WIRE)--Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders, today announced that an abstract describing the effects of darusentan on resistant hypertension (RHTN) has been selected for presentation at the International Society of Hypertension (ISH) to be held Oct. 15-19, 2006, in Fukuoka, Japan.

Read at BioSpace.com


comments powered by Disqus
Myogen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES